Tag Archives: Prof. Karl-Heinz Kuck M.D.

Medtronic: treating paroxysmal atrial fibrillation with cryoballoon catheter ablation results in cost savings as compared to radiofrequency ablation

Data from Landmark Trial Published in the Journal of the American Heart Association DUBLIN, 03-Aug-2017 — /EuropaWire/ — A new health economic analysis from the landmark FIRE AND ICE Trial, sponsored by Medtronic plc (NYSE: MDT), was published today in the Journal of … Read the full press release